Search results for "cancer diagnosis"

AI-driven HART blood tests demonstrate high accuracy in diverse patient populations and beyond cardiac disease

Association mission remains the same - better health through laboratory medicine

Explore the latest advances in cancer research from a focal event in the cancer community calendar

This launch represents an important step in Roche’s personalized healthcare strategy to fit treatments to patients who can benefit most from a specific medicine

Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems

The diagnostic assay can be used to help diagnose patients with non-small cell lung cancer

New Aptiva® APS IgG and APS IgM reagents enable early diagnosis of Antiphospholipid Syndrome in hard-to-diagnose autoimmune disease

Research partnership aims to build strong pharma and academic collaborations in sharing data and clinical samples to develop biomarker-based diagnostics for Alzheimer’s disease

Roche's assay to be used to find patients eligible for treatment with Tecentriq in combination with Abraxane

The vaccine quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor

Study shows blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90%

As the first laboratory to validate Ki-67 IHC MIB-1 pharmDx Quest plans to make testing available nationally by the end of October 2021

Discover how a rapid diagnosis between viral and bacterial pulmonary infections can minimize antibiotic usage in critical care

Discover the latest cutting-edge technology from Roche at the American Association of Clinical Chemistry 2023 Clinical Lab Expo

Olink is sponsoring a Cancer Biomarker Discovery Challenge for Innovative Researchers in Europe